| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/05/2002 | EP1210939A2 Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210936A1 Gelatin capsule |
| 06/05/2002 | EP1210935A1 Medicinal compositions for oral use |
| 06/05/2002 | EP1210934A2 Pharmaceutical carrier preparation applicable to mucosal surfaces and body tissues |
| 06/05/2002 | EP1210929A2 Cosmetic compositions comprising alkyl or alkenyl derivatives of succinic acid |
| 06/05/2002 | EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 06/05/2002 | EP1210361A1 Stabilisation of freeze-dried cake |
| 06/05/2002 | EP1210355A2 Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 06/05/2002 | EP1210350A1 Water soluble sdz-rad esters |
| 06/05/2002 | EP1210182A1 Permeabilizing biofilms |
| 06/05/2002 | EP1210138A1 Controlled delivery of bisphosphonates |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210127A1 Radiopharmaceutical products and their preparation procedure |
| 06/05/2002 | EP1210125A2 L-selectin contrast agents |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210120A1 Nerve cell growth modulators (amphibodies) |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210113A2 Combined vaccine compositions |
| 06/05/2002 | EP1210104A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 06/05/2002 | EP1210093A1 Degradable polymers |
| 06/05/2002 | EP1210091A1 Heartburn treatment |
| 06/05/2002 | EP1210085A2 Pharmaceutical solutions of levosimendan |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210074A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 06/05/2002 | EP1210069A2 Large porous particles by spray-drying |
| 06/05/2002 | EP1210068A2 Use of simple amino acids to form porous particles |
| 06/05/2002 | EP1210067A2 Modulation of release from dry powder formulations |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 06/05/2002 | EP1210040A2 Apparatus and method for anesthetizing the cervical region of a female |
| 06/05/2002 | EP1209988A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 06/05/2002 | EP1209971A1 Charge reversal of polyion complexes |
| 06/05/2002 | EP1121144B1 Stable concentrated insulin preparations for pulmonary delivery |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | EP1117420B1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 06/05/2002 | EP0960132B1 Polysaccharide, micro-organism and method for obtaining same, composition containing it and application |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0809506B1 Antimicrobial composition composed of controlled release glasses |
| 06/05/2002 | EP0799046B1 Stable solutions of 2-chloro-2'-deoxyadenosine |
| 06/05/2002 | EP0789580B1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 06/05/2002 | EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers |
| 06/05/2002 | EP0752851B1 Process for preparing a pharmaceutical formulation |
| 06/05/2002 | EP0741574B1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 06/05/2002 | EP0663951B1 Chitosan matrices for encapsulated cells |
| 06/05/2002 | EP0627914B1 Use of butylurea as contraceptive agent |
| 06/05/2002 | EP0625034B1 Skin adhesive hydrogel, its preparation and uses |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/05/2002 | CN1352634A Process for preparing amlodipine benzenesulphonate |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352560A Ziprasidone suspension |
| 06/05/2002 | CN1352549A Methods and devices for providing prolonged drug therapy |
| 06/05/2002 | CN1352530A Methods for lowering viscosity of glucomannan compositions |
| 06/05/2002 | CN1351868A Implanted slow-releasing antiseptic preparation and its preparing method |
| 06/05/2002 | CN1085987C Heterotelechelic block copolymers and process for producing same |
| 06/04/2002 | USRE37727 Applying at the site of pain, a plaster or gel, comprising from about 2-10% by weight of lidocaine at least in part as the free base in a formulation which provides for intradermal transport of said lidocaine, |
| 06/04/2002 | US6399798 Method of preparing alkylated salicylamides |
| 06/04/2002 | US6399777 Salts of arylpiperazinylalkylene heterocycle and a cyclodextrin; water soluble; stability |
| 06/04/2002 | US6399754 Sugar modified oligonucleotides |
| 06/04/2002 | US6399700 Comb copolymers for regulating cell-surface interactions |
| 06/04/2002 | US6399651 Method of treating dermatoses using avermectin compound |
| 06/04/2002 | US6399605 Ophthalmic composition comprising a beta -blocker |
| 06/04/2002 | US6399594 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient |
| 06/04/2002 | US6399591 Chargeable pharmaceutical tablets |
| 06/04/2002 | US6399590 Phosphoglycolipid and methods for its use |
| 06/04/2002 | US6399588 Cancer treatment method utilizing plasmids suitable for IL-2 expression |
| 06/04/2002 | US6399578 Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same |
| 06/04/2002 | US6399566 Mixture containing capsaicine, histamine or plant extract |
| 06/04/2002 | US6399385 Conjugating a genetically engineered virus with polyethylene glycol at ambient temperature for improved gene expression |
| 06/04/2002 | US6399368 A genetically engineered cloning vector containing a inducible promoter, leader sequence and a soluble t-cell receptor variable domain; therapy for autoimmune diseases and cancer |
| 06/04/2002 | US6399355 Lipolytic agent linked to a targeting agent. |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399104 Pharmaceutical compositions |
| 06/04/2002 | US6399102 Aerodynamically light particles for pulmonary drug delivery |
| 06/04/2002 | US6399101 Levothyroxine sodium and silicified microcrystalline cellulose; tablets; light, heat, and humidity stable |
| 06/04/2002 | US6399093 Method and composition to treat musculoskeletal disorders |
| 06/04/2002 | US6399087 Dissolving in a solvent, emulsification with water and surfactant |
| 06/04/2002 | US6399082 Alpha-hydroxy acid, diol and semi-occlusion vehicles |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399078 Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6398757 Gene therapeutic treatment of blood vessel associated disorders |
| 06/04/2002 | CA2239352C Injectable quinolone formulations |
| 06/04/2002 | CA2119262C Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 06/04/2002 | CA2103725C Composition for use in transdermal administration |
| 06/04/2002 | CA2078990C Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 06/04/2002 | CA2067754C Preparation for the application of agents in mini-droplets |
| 06/04/2002 | CA2014459C Targeted forms of methyltrithio antitumor agents |
| 06/03/2002 | WO2002000202A1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 05/30/2002 | WO2002042325A2 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |